CN112654705B - 用在治疗代谢疾病中的微小rna抑制剂 - Google Patents

用在治疗代谢疾病中的微小rna抑制剂 Download PDF

Info

Publication number
CN112654705B
CN112654705B CN201980058818.XA CN201980058818A CN112654705B CN 112654705 B CN112654705 B CN 112654705B CN 201980058818 A CN201980058818 A CN 201980058818A CN 112654705 B CN112654705 B CN 112654705B
Authority
CN
China
Prior art keywords
mir
inhibitor
fragment
composition
nucleotide sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201980058818.XA
Other languages
English (en)
Chinese (zh)
Other versions
CN112654705A (zh
Inventor
S·赫兹格
M·G·洛扎诺
T·斯查弗梅尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Helmholtz Zentrum München
Original Assignee
Helmholtz Zentrum München
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helmholtz Zentrum München filed Critical Helmholtz Zentrum München
Publication of CN112654705A publication Critical patent/CN112654705A/zh
Application granted granted Critical
Publication of CN112654705B publication Critical patent/CN112654705B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C12N2310/113—Antisense targeting other non-coding nucleic acids, e.g. antagomirs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/13—Decoys
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/30—Special therapeutic applications
    • C12N2320/31—Combination therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/30—Special therapeutic applications
    • C12N2320/32—Special delivery means, e.g. tissue-specific

Landscapes

  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CN201980058818.XA 2018-09-11 2019-09-10 用在治疗代谢疾病中的微小rna抑制剂 Active CN112654705B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
LULU100927 2018-09-11
LU100927 2018-09-11
PCT/EP2019/074056 WO2020053186A1 (en) 2018-09-11 2019-09-10 Microrna inhibitors for use in treating metabolic diseases

Publications (2)

Publication Number Publication Date
CN112654705A CN112654705A (zh) 2021-04-13
CN112654705B true CN112654705B (zh) 2024-07-02

Family

ID=63998726

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201980058818.XA Active CN112654705B (zh) 2018-09-11 2019-09-10 用在治疗代谢疾病中的微小rna抑制剂

Country Status (7)

Country Link
US (1) US12584126B2 (cg-RX-API-DMAC10.html)
EP (1) EP3850099B1 (cg-RX-API-DMAC10.html)
JP (3) JP7530836B2 (cg-RX-API-DMAC10.html)
CN (1) CN112654705B (cg-RX-API-DMAC10.html)
CA (1) CA3103175A1 (cg-RX-API-DMAC10.html)
DK (1) DK3850099T3 (cg-RX-API-DMAC10.html)
WO (1) WO2020053186A1 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7530836B2 (ja) 2018-09-11 2024-08-08 ヘルムホルツ・ツェントルム・ミュンヘン・ドイチェス・フォーシュンクスツェントルム・フュア・ゲズントハイト・ウント・ウンベルト・ゲーエムベーハー 代謝性疾患の処置において使用するためのマイクロrnaインヒビター
CN111228291B (zh) * 2020-03-20 2020-10-02 军事科学院军事医学研究院环境医学与作业医学研究所 miR-541在制备抗神经元细胞缺氧损伤药物中的应用及药物
CN121818694B (zh) * 2025-12-23 2026-07-28 内蒙古大学 改善胰岛素抵抗的miR-3963在制备药物中的应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112004923A (zh) * 2017-11-22 2020-11-27 迈索布拉斯特国际有限公司 细胞组合物及治疗方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4711955A (en) 1981-04-17 1987-12-08 Yale University Modified nucleotides and methods of preparing and using same
CA1223831A (en) 1982-06-23 1987-07-07 Dean Engelhardt Modified nucleotides, methods of preparing and utilizing and compositions containing the same
US5792608A (en) 1991-12-12 1998-08-11 Gilead Sciences, Inc. Nuclease stable and binding competent oligomers and methods for their use
US5525711A (en) 1994-05-18 1996-06-11 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Pteridine nucleotide analogs as fluorescent DNA probes
WO2014074874A1 (en) * 2012-11-09 2014-05-15 Regents Of The University Of Minnesota Osteosarcoma diagnostic and prognostic methods
EP2868746A1 (en) 2013-10-29 2015-05-06 Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts Micrornas modulating the effect of glucocorticoid signaling
WO2016065001A1 (en) * 2014-10-21 2016-04-28 University Of Massachusetts Recombinant aav variants and uses thereof
CN106267207A (zh) * 2015-06-05 2017-01-04 昆山彭济凯丰生物科技有限公司 通过miR-96进行减肥、降血糖和降血脂的方法和药物及其应用
JP7530836B2 (ja) 2018-09-11 2024-08-08 ヘルムホルツ・ツェントルム・ミュンヘン・ドイチェス・フォーシュンクスツェントルム・フュア・ゲズントハイト・ウント・ウンベルト・ゲーエムベーハー 代謝性疾患の処置において使用するためのマイクロrnaインヒビター

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112004923A (zh) * 2017-11-22 2020-11-27 迈索布拉斯特国际有限公司 细胞组合物及治疗方法

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Altered microRNA expression profiles in lung damage induced by nanosized SiO2;Yang H等;《Bioengineered》;第8卷(第1期);第45-54页 *
戴睿等.miR-541-3p靶向SPOCD1基因通过Wnt/β-catenin信号通路抑制乳腺癌细胞增殖,迁移和侵袭.《中国免疫学杂志》.2021,第37卷(第6期),第694-699页. *

Also Published As

Publication number Publication date
JP7893574B2 (ja) 2026-07-22
WO2020053186A1 (en) 2020-03-19
EP3850099B1 (en) 2025-09-03
JP2021535079A (ja) 2021-12-16
JP2026091891A (ja) 2026-06-04
CN112654705A (zh) 2021-04-13
JP7530836B2 (ja) 2024-08-08
US20210254067A1 (en) 2021-08-19
CA3103175A1 (en) 2020-03-19
EP3850099A1 (en) 2021-07-21
JP2024073525A (ja) 2024-05-29
DK3850099T3 (da) 2025-10-13
US12584126B2 (en) 2026-03-24

Similar Documents

Publication Publication Date Title
JP7837560B2 (ja) 安定性の向上を有する修飾オリゴヌクレオチドの合成
EP3277815B1 (en) Oligonucleotide compounds for treatment of preeclampsia and other angiogenic disorders
KR101791702B1 (ko) 비대칭 이중가닥 rna에 의한 kras의 특이적 저해를 위한 방법 및 조성물
JP2022078069A (ja) 二本鎖RNAによるα-1アンチトリプシンの特異的阻害のための方法及び組成物
EP2208499A1 (en) Nucleic acid capable of regulating the proliferation of cell
JP2024073525A (ja) 代謝性疾患の処置において使用するためのマイクロrnaインヒビター
US20230235322A1 (en) Rna editing inhibitors and methods of use
EP3037538A1 (en) Methods and compositions for the specific inhibition of beta-catenin by double-stranded rna
Wu et al. MiRNAs in human cancers: the diagnostic and therapeutic implications
US20150005365A1 (en) Methods for diagnosing and treating learning or mental disorders
EP3663403A1 (en) Rna-modulating agents
JP2025023131A (ja) 治療的使用のための、ヒト遺伝子JAK1又はJAK3の発現を標的とするSiRNA配列
EP2774989B1 (en) Double-stranded nucleic acid molecule for gene expression control
CA3224145A1 (en) Novel rna therapeutics and uses thereof
EP3647423A1 (en) HETERO DOUBLE-STRANDED antimiR
EP3476939A1 (en) Nucleic acid inhibiting expression of the mex3b gene, mex3b gene expression inhibitor, method for inhibiting mex3b gene expression, and prophylactic or therapeutic agent for disease caused by mex3b gene expression
CN114144526A (zh) Eph2a适配体及其用途
WO2005010185A1 (ja) Klf5遺伝子の発現を抑制するrna
JP7530106B2 (ja) Ihh発現を調節するための核酸複合体
CN102199603B (zh) 多靶位干扰rna分子及其应用
EP4653531A1 (en) Antisense oligomers targeting gfral and use thereof
KR20220169429A (ko) 타겟 유전자 발현을 조절할 수 있는 핵산 분자 및 이의 용도
WO2025195381A1 (zh) 一种靶向INHBE基因表达的siRNA及其缀合物和用途

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant